摘要:
A xylylene diisocynate composition, a preparation method therefor and the use thereof. The xylylene diisocynate composition includes xylylene diisocynate and 0.2-500 ppm of a compound represented by formula (1). A resin prepared from the provided xylylene diisocynate composition has an excellent discoloration resistance and can effectively inhibit yellowing and/or white turbidity thereof.
摘要:
In one embodiment, a photocurable composition can comprise a polymerizable material and a photoinitiator, wherein the polymerizable material includes an isocyanate group containing compound of formula (1): R1-R2-N═C═O (1), with R1 including a carbon-carbon double bond, and R2 being substituted or unsubstituted alkyl, aryl, or alkylaryl. An amount of 1 wt % to 10 wt % of the isocyanate group containing compound can cause a strong adhesion strength of the photocurable composition to a silicon substrate after curing, and may allow the omission of an adhesion layer between substrate and the photo-cured layer.
摘要:
The invention relates to polyureas having a weight-average molecular weight ranging from 5,000 to 70,000 g/mol, the preparation thereof, and the use thereof as rheology control agents. The invention further relates to rheology control agents containing polyureas and to the use thereof. The invention moreover relates to formulations containing polyureas.
摘要:
The present invention relates to a composite material comprising nanoporous particles and at least one binder constructed from at least one isocyanate and at least one polymer P selected from the group consisting of polyvinylamine, poly(meth)acrylic acid, poly(meth)acrylic ester, polyvinyl alcohol, polyvinylthiol and mixtures thereof, wherein said at least one binder is used in an amount of 0.1 to 20 wt %, based on the amount of nanoporous particles, a composition for producing a composite material of this type, a process for producing a composite material of this type, shaped articles comprising said composite material and the use of said composite material for thermal and/or acoustical insulation.
摘要:
Compounds selected from: where DRUG-OH, DRUG-COOH and DRUG-NH2 are biologically active compounds; each X is independently selected from —CH2COO— (glycolic acid moiety), —CH(CH3)COO— (lactic acid moiety), —CH2CH2OCH2COO— (dioxanone moiety), —CH2CH2CH2CH2CH2COO— (caprolactone moiety), —(CH2)yCOO—, where y is 2-4 or 6-24 and —(CH2CH2O)zCH2C—, where z is 2-24; each Y is independently selected from —COCH2O— (glycolic ester moiety), —COCH(CH3)O— (lactic ester moiety), —COCH2OCH2CH2O— (dioxanone ester moiety), —COCH2CH2CH2CH2CH2O— (caprolactone ester moiety), —CO(CH2)mO—, where m is 2-4 or 6-24 and —COCH2O(CH2CH2O)n— where n is between 2-24; R′ is hydrogen, benzyl or an alkyl group, the alkyl group being either straight-chained or branched; and p is 1-6. Multi-functional compounds and drug dimers, oligomers and polymers are also disclosed.
摘要:
A pressure-sensitive adhesive composition, comprising: (A) a (meth)acryl-based polymer; and (B) an ionic compound comprising an anion component and a cation component, wherein the anion component is at least one of an anion component represented by the general formula (1): (CnF2n+1SO2)2N−, (1) wherein n is an integer of 3 to 10, and an anion component represented by the general formula (2): CF2(CmF2mSO2)2N−, (2) wherein m is an integer of 2 to 10.
摘要翻译:一种压敏粘合剂组合物,其包含:(A)(甲基)丙烯酸类聚合物; 和(B)包含阴离子组分和阳离子组分的离子化合物,其中阴离子组分是由通式(1)表示的阴离子组分中的至少一种:(CnF2n + 1SO2)2N-,(1)其中n 为3〜10的整数,通式(2)表示的阴离子成分:CF 2(C m F 2 m SO 2)2 N - ,(2)其中,m为2〜10的整数。
摘要:
The present application teaches a coating having a biologically compatible compound conjugated to, or blended with, a polymer, wherein the polymer includes at least one olefin-derived unit and at least one unit derived from a vinyl alcohol, an allyl alcohol, or derivatives thereof.
摘要:
Absorbable polyurethanes, polyamides and polyester urethanes prepared from at least one compound selected from: or the diamines and diisocyanates thereof, wherein each X represents a member independently selected from —CH2COO— (glycolic acid moiety), —CH(CH3)COO— (lactic acid moiety), —CH2CH2OCH2COO— (dioxanone), —CH2CH2CH2CH2CH2COO— (caprolactone moiety), —(CH2)yCOO— where y is one of the numbers 2, 3, 4 or 6-24 inclusive, and —(CH2CH2O)z′CH2COO— where z′ is an integer between 2 and 24, inclusive; each Y represents a member independently selected from —COCH2O— (glycolic ester moiety), —COCH(CH3)O— (lactic ester moiety), —COCH2OCH2CH2O— (dioxanone ester), —COCH2CH2CH2CH2CH2O— (caprolactone ester), —CO(CH2)mO— where m is an integer between 2, 3, 4 or 6-24 inclusive, —COCH2O(CH2CH2O)n— where n is an integer between 2 and 24, inclusive; R′ is hydrogen, benzyl or an alkyl group, the alkyl group being either straight-chained or branched; p is an integer between 1 and 4, inclusive; and Rn represents one or more members selected from H, alkoxy, benzyloxy, aldehyde, halogen, carboxylic acid and —NO2, which is attached directly to an aromatic ring or attached through an aliphatic chain. Absorbable polymers prepared from these compounds are useful for drug delivery, tissue engineering, tissue adhesives, adhesion prevention and other implantable medical devices.